Vectus Biosystems Ltd (VBS) Company Profile

Vectus Biosystems Ltd Company Snapshot

Vectus Biosystems Ltd operates within the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Vectus Biosystems Ltd with three other miscellaneous service companies in Australasia: PYC Therapeutics Ltd (2019 sales of 250.00 Australian Dollars [US$178.96 ] ), Australian Primary Hemp Ltd (11,076.00 Australian Dollars [US$7,928.42 ] ), and BARD1 Life Sciences Ltd (8,731.00 Australian Dollars [US$6,249.82 ] ).

Sales Analysis. Sales fell dramatically in 2019: During the year ended June of 2019, sales at Vectus Biosystems Ltd were A$220.00 (US$157.48). This is a sharp decrease of 88.0% versus 2018, when the company's sales were A$1,827.00 .

Vectus Biosystems Ltd

Stock Data:

Recent Stock Performance:

Current Price (8/6/2020): .79
(Figures in Australian Dollars)

1 Week	n/a	13 Weeks	16.2%

4 Weeks	n/a	52 Weeks	95.1%

Vectus Biosystems Ltd Key Data:

Ticker:	VBS	Country:	Australia

Exchanges:	ASX	Major Industry:	Commercial Services & Supplies

		Sub Industry:	Commercial Physical Research

2019 Sales	220 (Year Ending Jan 2020).	Employees:	N/A

Currency:	Australian Dollars	Market Cap:	18,552,357

Fiscal Yr Ends:	June	Shares Outstanding:	23,483,996

Share Type:	Ordinary	Closely Held Shares:	12,851,634

Feedback | Terms and Conditions | Privacy Policy | Site Index

CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.